Finally, supplementation of neurotrophin-3 (NT-3), a neurotrophic factor crucial for Schwann-cell autocrine survival and regeneration, has been proposed to treat CMT1A [118]. The gene discussed is NTF3; the disease is Charcot-Marie-Tooth disease type 1A.